Usefulness of second rituximab maintenance after relapse in patients with follicular and mantle cell lymphoma.

Blanca Sanchez-Gonzalez; Eva Gimeno; Francesc Garcia-Pallarols; Agueda Ancochea; Antonio Salar

首页> 外文期刊>Leukemia and lymphoma >Usefulness of second rituximab maintenance after relapse in patients with follicular and mantle cell lymphoma.

【24h】

Usefulness of second rituximab maintenance after relapse in patients with follicular and mantle cell lymphoma.

机译：滤泡和甲状腺细胞淋巴瘤患者复发后的第二个rituximab维持的有用性。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The ghrelin levels were reduced after gastrectomy and did not recover by 12 months postoperatively. Further studies are needed to evaluate these results as the basis of a therapeutic trial.

机译：胃切除术后Ghrelin水平降低，并且术后未恢复12个月。需要进一步的研究来评估这些结果作为治疗试验的基础。

著录项

来源
《Leukemia and lymphoma》 |2014年第10期|共3页
作者
Blanca Sanchez-Gonzalez; Eva Gimeno; Francesc Garcia-Pallarols; Agueda Ancochea; Antonio Salar;
展开▼
作者单位

Department of Hematology Hospital del Mar - IMIM Barcelona Spain;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 复发性晚期滤泡性淋巴瘤的IDEC-C2B8(利妥希玛)抗CD20抗体治疗:德国低度恶性淋巴瘤研究组Ⅱ期研究结果 [J] . 李登举, 唐锦治中德临床肿瘤学杂志（英文版） . 2001,第004期
2. Usefulness of second rituximab maintenance after relapse in patients with follicular and mantle cell lymphoma. [J] . Blanca Sanchez-Gonzalez, Eva Gimeno, Francesc Garcia-Pallarols, Leukemia and lymphoma . 2014,第10期

机译：滤泡性和套细胞淋巴瘤患者复发后第二次利妥昔单抗维持的有效性。
3. Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma. [J] . Robinson KS, Williams ME, van-der-Jagt RH, Journal of Clinical Oncology . 2008,第27期

机译：苯达莫司汀加利妥昔单抗治疗复发性惰性B细胞和套细胞非霍奇金淋巴瘤的II期多中心研究。
4. The effect of Rituximab on patients with follicular and mantle-cell lymphoma. Swiss Group for Clinical Cancer Research (SAKK). [J] . Ghielmini M, Schmitz SF, Burki K, Annals of oncology: official journal of the European Society for Medical Oncology . 2000,第Suppla1期

机译：利妥昔单抗对滤泡性和套细胞淋巴瘤患者的影响。瑞士临床癌症研究小组（SAKK）。
5. Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma [C] . Bohua Li, Hao Wang, Yajun Guo, International conference of molecular simulations and applied informatics technologies . 2012

机译：具有抗利妥昔单抗的B细胞淋巴瘤的有效抗肿瘤活性的利妥昔单抗变体的表征
6. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
7. Phase II trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphoma [O] . Robert A. Baiocchi, Lapo Alinari, Mark E. Lustberg, -1

机译：Rituximab和Bortezomib在复发或难治性地幔细胞和滤泡淋巴瘤患者中试验
8. Radioimmunotherapy with 177 Lu-DOTA-Rituximab: Final Results of a Phase I/II Study in 31 Patients with Relapsing Follicular, Mantle Cell, and Other Indolent B-Cell Lymphomas [O] . Flavio Forrer, Catharina Oechslin-oberholzer, Benedetta Campana, 2013

机译：用177 Lu-DOTa-Rituximab进行放射免疫治疗：31例复发性卵泡，地幔细胞和其他惰性B细胞淋巴瘤患者的I / II期研究的最终结果
9. Retrovirus Isolated From Mantle Histiocytes in Mantle Cell Lymphoma. [R] . McGrath, M. S., Herndier, B. 2004

机译：从地幔细胞淋巴瘤中的地幔组织细胞分离的逆转录病毒。

Usefulness of second rituximab maintenance after relapse in patients with follicular and mantle cell lymphoma.

摘要

著录项

相似文献

相关主题

期刊订阅